Table 1 Comparison of clinical and laboratory test result among three groups.

From: The clinical parameters for the diagnosis of hepatitis B virus related acute-on-chronic liver failure with sepsis

N = 43

Group A (n = 14)

Group B (n = 10)

Group C (n = 19)

F

p value

Age

46.2 ± 12.1

46.4 ± 13.5

42.2 ± 8.7

0.718

0.494

Course from start to transplantation

33.4 ± 24.2

13.6 ± 9.3*

10.8 ± 7.6*

9.399

0.000

ALT AA (U/L)

369.3 ± 413.1

923.7 ± 699.0

429.2 ± 709.3

2.684

0.081

ALT BLT (U/L)

81.6 ± 66.4

754.5 ± 1084.7*

120.6 ± 102.5#

6.015

0.005

AST AA (U/L)

252.2 ± 233.3

624.9 ± 563.2

465.4 ± 771.1

1.185

0.316

AST BLT (U/L)

86.6 ± 32.4

278.5 ± 232.5*

181.7 ± 222.1

3.129

0.055

TBIL AA (umol/L)

422.9 ± 183.5

318.4 ± 135.1

328.7 ± 125.7

2.051

0.142

TBIL BLT (umol/L)

563.5 ± 191.8

383.9 ± 157.6*

438.3 ± 154.7*

3.800

0.031

PTA% AA

29.0 ± 10.8

26.9 ± 10.4

28.7 ± 10.2

0.129

0.879

PTA% BLT

29.2 ± 13.1

21.6 ± 10.9

24.9 ± 9.9

1.382

0.263

CHE AA (U/L)

3174.7 ± 1247.0

3527.5 ± 970.8

2967.8 ± 1171.4

0.769

0.470

CHE BLT (U/L)

3140.0 ± 1584.8

3127.4 ± 1390.3

2705.7 ± 1082.5

0.549

0.582

ALB AA (g/L)

31.0 ± 5.1

31.7 ± 4.3

29.8 ± 3.5

0.610

0.548

ALB BLT (g/L)

32.4 ± 5.3

32.9 ± 3.2

30.0 ± 3.5

2.032

0.144

WBC AA (×109/L)

6.7 ± 4.7

8.8 ± 3.5

5.0 ± 1.6#

4.316

0.020

WBCBLT (×109/L)

11.2 ± 4.5

9.4 ± 4.2

7.0 ± 8.7

1.616

0.211

WBCBLT/WBC AA

2.3 ± 1.6

1.1 ± 0.6*

1.4 ± 1.5

2.854

0.069

PLTAA (×109/L)

83.9 ± 41.1

118.8 ± 53.6

79.6 ± 45.7

2.542

0.091

PLTBLT (×109/L)

48.1 ± 20.8

109.8 ± 52.2*

74.7 ± 38.0#

7.910

0.001

PLTBLT/PLT AA

0.7 ± 0.3

0.9 ± 0.2*

1.0 ± 0.2*

8.721

0.001

PLTAA/WBCAA

16.1 ± 7.2

15.2 ± 8.5

16.4 ± 9.3

0.066

0.937

PLTBLT/WBCBLT

4.6 ± 2.0

12.5 ± 4.9*

14.9 ± 8.6*

11.28

0.000

(WBCBLT/WBC AA)/(PLTBLT/PLT AA)

3.9 ± 2.0

1.2 ± 0.6*

1.5 ± 1.8*

10.475

0.000

  1. AA: at admission; BLT: before liver transplantation.
  2. *Comparison with group A, p < 0.05; #Comparison with group B, p < 0.05.